title: [Hemato-encephalic barrier function in strokes in patients with arterial hypertension under drug correction].
authors.forename: V V
authors.initials: VV
authors.lastname: Dunaev
authors.forename: I A
authors.initials: IA
authors.lastname: Mazur
authors.forename: A G
authors.initials: AG
authors.lastname: Petrenko
authors.forename: I F
authors.initials: IF
authors.lastname: Belenichev
authors.forename: S I
authors.initials: SI
authors.lastname: Kovalenko
authors.forename: V N
authors.initials: VN
authors.lastname: Klimenko
authors.forename: M M
authors.initials: MM
authors.lastname: Guĭtur
authors.forename: V A
authors.initials: VA
authors.lastname: Vizir
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use; D052999:Quinazolinones; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000975:Antioxidants; D006834:Hydrazines; D011799:Quinazolines; D052999:Quinazolinones; C085354:4-hydrazinoquinazoline